Schistosomes-proteomics studies for potential novel vaccines and drug targets

Drug Discovery Today

Volumn 14, Issue 9-10, 2009, Pages 472-478

  DeMarco, Ricardo ^a   Verjovski Almeida, Sergio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; PRAZIQUANTEL; VACCINE;

DATA BASE; DNA SEQUENCE; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HOST PARASITE INTERACTION; LIFE CYCLE; MOLECULAR BIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; REVIEW; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, HELMINTH; ANTIGENS, SURFACE; DATABASES, NUCLEIC ACID; DRUG DELIVERY SYSTEMS; GENES, HELMINTH; HUMANS; LIFE CYCLE STAGES; PROTEOMICS; SCHISTOSOMA; SCHISTOSOMIASIS; VACCINES;

EID: 67349284653     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.01.011     Document Type: Review

References (66)

1. WHO. TDR Strategic Direction for Research: Schistosomiasis (2002), World Health Organization
2. Ribeiro-dos-Santos G., et al. Schistosomiasis-a century searching for chemotherapeutic drugs. Parasitol. Res. 99 (2006) 505-521
3. Hagan P., et al. Schistosomiasis control: keep taking the tablets. Trends Parasitol. 20 (2004) 92-97
4. Doenhoff M., et al. Praziquantel and the control of schistosomiasis. Parasitol. Today 16 (2000) 364-366
5. Fenwick A., et al. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 19 (2003) 509-515
6. Stelma F.F., et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53 (1995) 167-170
7. Ismail M., et al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 55 (1996) 214-218
8. Ismail M., et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
9. Fallon P.G., et al. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp. Parasitol. 86 (1997) 29-36
10. Liang Y.S., et al. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Ann. Trop. Med. Parasitol. 95 (2001) 715-723
11. Liang Y.S., et al. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int. J. Parasitol. 31 (2001) 1227-1235
12. Gryseels B., et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 6 (2001) 864-873
13. Danso-Appiah A., and De Vlas S.J. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol. 18 (2002) 125-129
14. Pearce E.J., et al. The initiation and function of Th2 responses during infection with Schistosoma mansoni. Adv. Exp. Med. Biol. 452 (1998) 67-73
15. Soisson L.M., et al. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J. Immunol. 149 (1992) 3612-3620
16. Reynolds S.R., et al. T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J. Immunol. 149 (1992) 3995-4001
17. Reynolds S.R., et al. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J. Immunol. 152 (1994) 193-200
18. Tendler M., et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 269-273
19. Boulanger D., et al. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni. Parasite Immunol. 17 (1995) 361-369
20. Pearce E.J. Progress towards a vaccine for schistosomiasis. Acta Trop. 86 (2003) 309-313
21. Wilson R.A., and Coulson P.S. Schistosome vaccines: a critical appraisal. Mem. Inst. Oswaldo Cruz 101 Suppl. 1 (2006) 13-20
22. Capron A., et al. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol. 21 (2005) 143-149
23. Verjovski-Almeida S., et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet. 35 (2003) 148-157
24. Hu W., et al. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat. Genet. 35 (2003) 139-147
25. Wilson R.A., et al. Oming in on schistosomes: prospects and limitations for post-genomics. Trends Parasitol. 23 (2007) 14-20
26. Verjovski-Almeida S., et al. Use of a 44k oligoarray to explore the transcriptome of Schistosoma mansoni adult worms. Exp. Parasitol. 117 (2007) 236-245
27. Skelly P.J., et al. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int. J. Parasitol. 33 (2003) 363-369
28. Krautz-Peterson G., et al. Optimizing gene suppression in schistosomes using RNA interference. Mol. Biochem. Parasitol. 153 (2007) 194-202
29. Braschi S., et al. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6 (2006) 1471-1482
30. van Balkom B.W., et al. Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J. Proteome Res. 4 (2005) 958-966
31. Curwen R.S., et al. Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Mol. Cell. Proteomics 5 (2006) 835-844
32. Cass C.L., et al. Proteomic analysis of Schistosoma mansoni egg secretions. Mol. Biochem. Parasitol. 155 (2007) 84-93
33. Liu F., et al. New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog. 2 (2006) e29
34. Davies M.N., and Flower D.R. Harnessing bioinformatics to discover new vaccines. Drug Discov. Today 12 (2007) 389-395
35. Pizza M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287 (2000) 1816-1820
36. Maione D., et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309 (2005) 148-150
37. Almeida R., et al. From genomes to vaccines: leishmania as a model. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357 (2002) 5-11
38. Bhatia V., et al. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening. Infect. Immun. 72 (2004) 6245-6254
39. Stober C.B., et al. From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine 24 (2006) 2602-2616
40. Brito C.F., et al. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein. Scand. J. Immunol. 51 (2000) 595-601
41. Coler R.N., et al. Identification of Mycobacterium tuberculosis vaccine candidates using human CD4(+) T-cells expression cloning. Vaccine 27 (2009) 223-233
42. Curwen R.S., et al. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol. Biochem. Parasitol. 138 (2004) 57-66
43. Cheng G.F., et al. Proteomic analysis of differentially expressed proteins between the male and female worm of Schistosoma japonicum after pairing. Proteomics 5 (2005) 511-521
44. Chalmers I.W., et al. Developmentally regulated expression, alternative splicing and distinct sub-groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL) gene family. BMC Genomics 9 (2008) 89
45. DeMarco R., et al. Molecular characterization and immunolocalization of Schistosoma mansoni ATP-diphosphohydrolase. Biochem. Biophys. Res. Commun. 307 (2003) 831-838
46. Skelly P.J., and Shoemaker C.B. Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3642-3646
47. Braschi S., and Wilson R.A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell. Proteomics 5 (2006) 347-356
48. Tran M.H., et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 12 (2006) 835-840
49. Cardoso F.C., et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl. Trop. Dis. 2 (2008) e308
50. Perez-Sanchez R., et al. Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics 6 Suppl. 1 (2006) S226-S236
51. Perez-Sanchez R., et al. A proteomic approach to the identification of tegumental proteins of male and female Schistosoma bovis worms. Mol. Biochem. Parasitol. 161 (2008) 112-123
52. Liu F., et al. Insight into the host-parasite interplay by proteomic study of host proteins copurified with the human parasite, Schistosoma japonicum. Proteomics 7 (2007) 450-462
53. DeMarco R., et al. Schistosome albumin is of host, not parasite, origin. Int. J. Parasitol. 37 (2007) 1201-1208
54. Guillou F., et al. Excretory-secretory proteome of larval Schistosoma mansoni and Echinostoma caproni, two parasites of Biomphalaria glabrata. Mol. Biochem. Parasitol. 155 (2007) 45-56
55. Knudsen G.M., et al. Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol. Cell. Proteomics 4 (2005) 1862-1875
56. Dvorak J., et al. Differential use of protease families for invasion by schistosome cercariae. Biochimie 90 (2008) 345-358
57. Hansell E., et al. Proteomic analysis of skin invasion by blood fluke larvae. PLoS Negl. Trop. Dis. 2 (2008) e262
58. Doenhoff M.J. A role for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis. Parasitology 115 Suppl. (1997) S113-S125
59. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
60. Rigaut G., et al. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17 (1999) 1030-1032
61. Gavin A.C., et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415 (2002) 141-147
62. Bouwmeester T., et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat. Cell Biol. 6 (2004) 97-105
63. Burckstummer T., et al. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat. Methods 3 (2006) 1013-1019
64. Faria-Campos A.C., et al. BNDb-biomolecules nucleus database: an integrated proteomics and transcriptomics database. Genet. Mol. Res. 6 (2007) 937-945
65. Liu F., et al. SjTPdb: integrated transcriptome and proteome database and analysis platform for Schistosoma japonicum. BMC Genomics 9 (2008) 304
66. Zerlotini A., et al. SchistoDB: a Schistosoma mansoni genome resource. Nucleic Acids Res. 37 Database issue (2009) D579-D582